Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.11.13.566887

Guild-Level Gut Microbial Alterations Associate with Non-hepatitis Virus related Hepatocellular Carcinoma

Abstract

The gut microbiota of hepatocellular carcinoma (HCC) is different from that of cohort without HCC. However, the relationship between non-hepatitis virus related HCC and gut microbial alterations remains elusive. In this work, we studied the gut microbial data in Sequence Read Archive (SRA) database from 58 healthy controls (HC), 31 patients with nonalcoholic fatty liver disease (NAFLD), 206 patients with hepatitis B viruses, 35 patients with HBV related HCC (B-HCC), and 22 patients with non-HBV or non-HCV related HCC (NBNC-HCC). Depend on guild-based analysis, 27 gut bacterial co-abundance groups (CAGs) were established. By studying these CAGs, we found the gut microbial overall structure and composition differed among patients with NBNC-HCC, B-HCC, other liver diseases, and healthy cohort, such as members from Lachnospiraceae, Veillonellaceae, and Prevotella. The network calculated by these CAGs in patients with HCC showed less interactions than that in healthy cohort. The specific CAGs showed correlated to the development of HCC. In addition, gut bacterial dysbiosis index, which was calculated by significantly altered CAGs in patients with NBNC-HCC compared with healthy cohort, showed potential diagnostic power of NBNC-HCC. Therefore, this study shows a new way toward understanding the role of the gut microbiome in patients with non-hepatitis virus related HCC. IMPORTANCEGut microbiome may play an important role in the pathogenesis and development of hepatocellular carcinoma. However, the relationship between non-hepatitis virus related hepatocellular carcinoma and gut microbiome should be further understood. In the current work, we found the alterations of gut microbial structure, composition, and network robustness in these patients by guild-based data analysis. Specific gut bacteria in these patients were related to clinical parameters, such as blood biochemical indexes. More importantly, gut bacterial bio-markers, which can discriminate these patients and cohort without this disease, were showed in this study. Thus, our study suggests that these guild-level gut bacteria may contribute to the development of non-hepatitis virus related hepatocellular carcinoma. This provides a new direction for future studies, which aims to show the importance of the gut microbiome in hepatocellular carcinoma.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Xu, Y., Ye, H., Meng, X., Zhang, S., Zhang, Y., Chen, Y.. 2023-11-13. Guild-Level Gut Microbial Alterations Associate with Non-hepatitis Virus related Hepatocellular Carcinoma. https://doi.org/10.1101/2023.11.13.566887

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗